GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $373,396,000 | -6.0% | 8,507,405 | -5.4% | 0.02% | +10.0% |
Q1 2022 | $397,398,000 | -1.1% | 8,994,904 | -0.1% | 0.02% | +5.3% |
Q4 2021 | $402,013,000 | +14.3% | 9,007,976 | -0.8% | 0.02% | 0.0% |
Q3 2021 | $351,772,000 | -4.9% | 9,079,035 | -0.9% | 0.02% | 0.0% |
Q2 2021 | $369,759,000 | +8.6% | 9,163,297 | -2.2% | 0.02% | -5.0% |
Q1 2021 | $340,424,000 | -4.0% | 9,373,894 | -1.4% | 0.02% | -9.1% |
Q4 2020 | $354,623,000 | -0.9% | 9,510,345 | +1.3% | 0.02% | -8.3% |
Q3 2020 | $357,910,000 | -6.9% | 9,390,232 | +0.8% | 0.02% | -14.3% |
Q2 2020 | $384,283,000 | +9.5% | 9,317,126 | +2.1% | 0.03% | -9.7% |
Q1 2020 | $351,063,000 | -18.9% | 9,123,000 | +0.0% | 0.03% | +3.3% |
Q4 2019 | $433,074,000 | +6.5% | 9,121,751 | -3.2% | 0.03% | 0.0% |
Q3 2019 | $406,683,000 | +3.5% | 9,425,973 | -2.8% | 0.03% | +3.4% |
Q2 2019 | $392,990,000 | -4.6% | 9,701,155 | -0.2% | 0.03% | -9.4% |
Q1 2019 | $411,997,000 | +7.7% | 9,720,629 | -1.6% | 0.03% | -8.6% |
Q4 2018 | $382,418,000 | -4.2% | 9,883,390 | -0.5% | 0.04% | +12.9% |
Q3 2018 | $399,034,000 | -1.0% | 9,933,608 | -0.7% | 0.03% | -8.8% |
Q2 2018 | $403,100,000 | +2.0% | 10,000,022 | -1.1% | 0.03% | 0.0% |
Q1 2018 | $395,077,000 | +8.5% | 10,112,019 | -1.5% | 0.03% | +17.2% |
Q4 2017 | $363,984,000 | -13.1% | 10,261,757 | -0.5% | 0.03% | -19.4% |
Q3 2017 | $418,701,000 | -6.1% | 10,312,810 | -0.2% | 0.04% | -7.7% |
Q2 2017 | $445,715,000 | +0.8% | 10,336,607 | -1.5% | 0.04% | 0.0% |
Q1 2017 | $442,338,000 | +8.4% | 10,491,299 | -1.0% | 0.04% | +2.6% |
Q4 2016 | $408,238,000 | -9.2% | 10,600,829 | +1.7% | 0.04% | -15.6% |
Q3 2016 | $449,426,000 | -1.0% | 10,420,261 | -0.5% | 0.04% | -8.2% |
Q2 2016 | $453,884,000 | +8.0% | 10,472,620 | +1.1% | 0.05% | +8.9% |
Q1 2016 | $420,149,000 | +0.7% | 10,361,271 | +0.2% | 0.04% | -2.2% |
Q4 2015 | $417,098,000 | +4.4% | 10,337,024 | -0.6% | 0.05% | -2.1% |
Q3 2015 | $399,708,000 | -8.6% | 10,395,524 | -1.0% | 0.05% | 0.0% |
Q2 2015 | $437,237,000 | -11.1% | 10,497,901 | -1.5% | 0.05% | -6.0% |
Q1 2015 | $491,986,000 | +7.4% | 10,660,587 | -0.5% | 0.05% | +8.7% |
Q4 2014 | $458,103,000 | -7.7% | 10,718,376 | -0.7% | 0.05% | -13.2% |
Q3 2014 | $496,188,000 | -14.2% | 10,793,744 | -0.2% | 0.05% | -14.5% |
Q2 2014 | $578,118,000 | -0.6% | 10,809,995 | -0.7% | 0.06% | -6.1% |
Q1 2014 | $581,427,000 | -46.0% | 10,882,049 | -51.2% | 0.07% | -4.3% |
Q4 2013 | $1,077,370,000 | +94.3% | 22,291,888 | +101.7% | 0.07% | +1.5% |
Q3 2013 | $554,617,000 | -0.9% | 11,054,738 | -1.3% | 0.07% | -6.8% |
Q2 2013 | $559,695,000 | – | 11,200,614 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |